欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/H/1167/001
药品名称Xonvea MR 20 mg/20 mg modified-release tablets
活性成分
    • Doxylamine succinate 20.0 mg
    • Pyridoxine hydrochloride 20.0 mg
剂型Modified-release tablet
上市许可持有人Exeltis Healthcare S.L. Avenida Miralcampo 7, Azuqueca De Henares, Guadalajara, 19200, Spain
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Czechia (CZ)
      Bonjesta
    • Netherlands (NL)
    • Slovakia (SK)
    • Luxembourg (LU)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Belgium (BE)
      Bonjesta 20 mg/20 mg tabletten met gereguleerde afgifte
    • Latvia (LV)
    • Poland (PL)
      Bonjesta
    • Lithuania (LT)
      -
    • Estonia (EE)
    • Hungary (HU)
许可日期2023/01/18
最近更新日期2025/02/03
药物ATC编码
    • R06AA59 doxylamine, combinations
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase